Drug and Gene Delivery

Revolutionary new technologies have broadened our ability to deliver biological material – drugs and genes – to target tissues for studying and treating disease.

Over the past 15 years, major breakthroughs in delivery technologies – particularly liposomal and polymer nanoparticle-based – have fueled the rapid development of new pharmaceutical applications.

These new technologies have enabled enhancements such as increased permeation rate, targeted and time-regulated delivery, as well as improvements in the physicochemical interactions between drugs, genes and delivery vehicles.

At Akron, we have extensive experience developing nanoparticle-based drug and gene delivery technologies, particularly those based on liposomes and polymeric nanoparticles, to achieve sustained and targeted delivery of cargo.

For collaborations and custom solutions, or to just inquire how this technology could help your current efforts, get in touch with us.